Test Product,A single dose of Sitagliptin/Metformin 50/1000-
Sponsors
Novartis (Thailand) Ltd.
Conditions
Healthy volunteers
Healthy volunteers
Bioequivalence
Sitagliptin
Metiformin
Fixed dose combunation tablets
Pharmacokinetic study
Phase 1
A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Sitagliptin Phosphate Equivalent to Sitagliptin 50 mg and Metformin Hydrochloride 500 mg in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20200604004
Start: 2020-10-12Target: 32Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of Fixed Dose Combination Tablets of Sitagliptin Phosphate Equivalent to Sitagliptin 50 mg and Metformin Hydrochloride 1000 mg in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20200605001
Start: 2020-09-01Target: 32Updated: 2026-08-03